medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2017, Número 1

Siguiente >>

Salud Mental 2017; 40 (1)


Sexually transmitted infections and substance use disorders: evidence and challenges in Mexico

Marín-Navarrete R, Magis-Rodríguez C, Strathdee SA

Idioma: Ingles.
Referencias bibliográficas: 49
Paginas: 1-4
Archivo PDF: 203.77 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Aceijas, C. & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal on Drug Policy, 18, 352-358. DOI: http://dx.doi.org/10.1016/j.drugpo.2007.04.004

  2. Alvarado-Esquivel, C., Sablon, E., Martinez-Garcia, S. & Estrada-Martinez, Z. (2005). Hepatitis virus and HIV infections in inmutes of a state correccional facility in Mexico. Epidemiology & Infection, 133, 679-685. DOI: https://doi. org/10.1017/S0950268805003961

  3. Anaya, H. D., Hoang, T., Golden, J. F., Goetz, M. B., Gifford, A., Bowman, C., … Asch, S. M. (2008). Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. Journal of General Internal Medicine, 23(6), 800-7. DOI:10.1007/s11606-008-0617-x

  4. Barta, W.D., Portnoy, D.B., Kiene, S.M., Tennen, H., Abu-Hasaballah, K.S. & Ferrer, R. (2008). A daily process investigation of alcohol-involved sexual risk behavior among economically disadvantaged problem drinkers living with HIV/ AIDS. AIDS and Behavior, 12, 729-740. DOI: 10.1007/s10461-007-9342-4

  5. Brown, J.L. & Vanable, P.A. (2007). Alcohol use, partner type, and risky sexual behavior among college students: Findings from an event level study. Addictive Behaviors, 32, 2940-2952. http://dx.doi.org/10.1016/j.addbeh.2007.06.011

  6. Campollo, O., Román, S., Panduro, A., Hernández, G., Díaz-Barriga, L., Balanzario, M.C. & Cunningham, J.K. (2012). Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug and Alcohol Dependence, 123, 269-272. http://dx.doi.org/10.1016/j.drugalcdep.2011.11.009

  7. Centro Nacional para la Prevención y Control del VIH-Sida (2006). Guía para la aplicación de la prueba rápida. México: SSA.

  8. Centro Nacional para la Prevención y Control del VIH-Sida (2011). El VIH/SIDA en México 2011. Numeralia epidemiológica. México: SSA.

  9. Cohen, M. S., & Gay, C. L. (2010). Treatment to prevent transmission of HIV-1. Clinical Infectious Diseases, 50(Supplement 3), S85-S95. DOI: 10.1086/651478

  10. Deiss, R., Lozada, R.M., Burgos, J.L., Strahdee, S.A., Gallardo, M., Cuevas, J., & Garfein, R.S. (2012). HIV Prevalence and Sexual Risk Behavior among Non-Injection Drug Users in Tijuana, Mexico. Global Public Health, 7, 175-183. DOI: http://dx.doi.org/10.1080/17441692.2010.549141

  11. Edlin, B.R. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology, 36, S210-9. DOI: 10.1002/hep.1840360727

  12. Evon, D. M., Esserman, D. A, Bonner, J. E., Rao, T., Fried, M. W., & Golin, C. E. (2013). Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence. Journal of Viral Hepatitis, 20(8), 536-49. DOI: 10.1111/jvh.12079

  13. Grebely, J. & Tyndall, M.W. (2011). Management of HCV and HIV infections among people who inject drugs. Current Opinion in HIV and AIDS, 6, 501-7. DOI: 10.1097/COH.0b013e32834bcb36

  14. Hall, H. I., Holtgrave, D. R., & Maulsby, C. (2012). HIV transmission rates from persons living with HIV who are aware and unaware of their infection. Aids, 26(7), 893-896. DOI: 10.1097/QAD.0b013e328351f73f

  15. Hepatitis B Foundation. (2014). Statistics. Available in: http://www.hepb.org/hepb/ statistics.htm

  16. Ho, S.B., Groessl, E., Dollarhide, A., Robinson, S., Kravetz, D., & Dieperink, E. (2008). Management of chronic hepatitis C in veterans: the potential of integrated care models. The American Journal of Gastroenterology, 103, 1810-23. DOI:10.1111/j.1572-0241.2008.01877.x

  17. Kyle, T. L., Horigian, V. E., Tross, S., Gruber, V. A., Pereyra, M., Mandler, R. N., ... & Metsch, L. R. (2015). Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS and Behavior, 19(3), 536-542. DOI: 10.1007/s10461-014-0864-2

  18. Lai, C., Gane, E., Liaw, Y. Hsu, C., Thongsawsat, S., Wang, Y… Brown, N. A. (2007). Telbivudine versus lamivudine in patients with chronic hepatitis B. New England Journal of Medicine, 357, 2576-2588. DOI: 10.1056/NEJMoa066422

  19. Lalesta, M., Dillon, B., Padilla, S., Brooks, L., Raveneau, L., & Metcalf, C. (2000). Experience with HIV/STD prevention counseling with a rapid HIV test and counseling quality assurance (Respect-2). 2000 National STD Prevention Conference, Milwaukee, WI.

  20. Leber, W., McMullen, H., Anderson, J., Marlin, N., Santos, A. C., Bremner, S., ... & Griffiths, C. (2015). Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial. The Lancet HIV, 2(6), e229-e235. DOI: http://dx.doi.org/10.1016/S2352-3018(15)00059-4

  21. Lehman, J.S., Allen, D.M., Green, T.A. & Onorato, I.M. (1994). HIV infection among non–injecting drug usersentering drug treatment, United States, 1989–1992. Field Services Branch. AIDS, 8, 1465-1469.

  22. Lieveld, F. I., van Vlerken, L. G., Siersema, P. D., & van Erpecum, K. J. (2013). Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review. Annals of Hepatology, 12(3), 380-91.

  23. Lozano-Verduzco, I., Marín-Navarrete, R., Romero-Mendoza, M., & Tena-Suck, A. (2016). Experiences of Power and Violence in Mexican Men Attending Mutual- Aid Residential Centers for Addiction Treatment. American Journal of Men’s Health. 10(3) 237–249. DOI: 10.1177/1557988314565812

  24. Lozano-Verduzco, I., Mendoza-Romero, M. & Marín-Navarrete, R. (2016). Violence narratives of Mexican women treated in mutual-aid residential centers for addiction treatment. Substance Abuse Treatment, Prevention, and Policy. 11:39, 1-10. DOI: 10.1186/s13011-016-0083-0

  25. Magis-Rodriguez, C., Brouwer, K.C., Morales, S., Gayet, C., Lozada, R., Ortíz-Mondragón, R.,... Strathdee, S.A. (2005). HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. Journal of Psychoactive Drugs, 37, 333–339. DOI: http://dx.doi.org/10 .1080/02791072.2005.10400528

  26. Marín-Navarrete, R., Medina-Mora ME, Horigian VE, Salloum I., Villalobos-Gallegos L. & Fernandez-Mondragón, J. (2016). Co- Occurring disorders: A challenge for Mexican community based-residential care facilities for substance use. Journal of Dual Diagnosis, 12:3-4, 261-270. DOI: 10.1080/15504263.2016.1220207.

  27. Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. JAIDS Journal of Acquired Immune Deficiency Syndromes, 39(4), 446-453. DOI: 10.1097/01.qai.0000151079.33935.79

  28. Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., ... & Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. The Lancet, 372(9651), 1733-1745. DOI: http://dx.doi.org/10.1016/S0140-6736(08)61311-2

  29. Mathurin, P., Canva, V., Dharancy, S. & Paris, J.C. (2002). Treatment of chronic hepatitis C and alcohol consumption. Gastroentérologie Clinique et Biologique, 26, B248-51.

  30. Moirand, R., Bilodeau, M., Brissette, S. & Bruneau, J. (2007). Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage. Canadian Journal of Gastroenterology & Hepatolgy, 21, 355-361. DOI: http://dx.doi.org/10.1155/2007/576765

  31. Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D. & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378, 571–583. DOI: http://dx.doi.org/10.1016/S0140-6736(11)61097-0

  32. Organización Mundial de la Salud (OMS, 2014a). Hepatitis C. Disponible en: http:// www.who.int/mediacentre/factsheets/fs164/es/ Organización Mundial de la Salud (OMS, 2014b). Eliminación Mundial de la Sífilis Congénita: fundamentos y estrategia para la acción. Disponible en: http://www. who.int/reproductivehealth/publications/rtis/9789241595858/es/ Pagano A, García V, Recarte C, Lee JP. Sociopolitical contexts for addiction recovery: Anexos in U.S. Latino communities. International Journal of Drug Policy. 2016; 37:52-9. DOI: 10.1016/j.drugpo.2016.08.002.

  33. Page, K., Hahn, J. A., Evans, J., Shiboski, S., Lum, P., Delwart, E., . . . Busch, M. P. (2009). Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection. Journal of Infectious Diseases, 200, 1216–1226. DOI: 10.1086/605947

  34. Pai, N.P., Vadnais, C., Denkinger, C., Engel, N. & Pai, M. (2012). Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low And Middle-Income Countries. PLoS Medicine, 9, 1-7. DOI: http://dx.doi. org/10.1371/journal.pmed.1001306

  35. Peters, M.G. & Terrault, N.A. (2002). Alcohol use and hepatitis C. Hepatology, 36, S220-5. DOI: 10.1053/jhep.2002.36811

  36. Piasecki, B. A., Lewis, J. D., Reddy, K. R., Bellamy, S. L., Porter, S. B., Weinrieb, R. M., . . . Chang, K. M. (2004). Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology, 40, 892–899. DOI: 10.1002/hep.1840400419

  37. Poustchi, H., Esmaili, S., Mohamadkhani, A., Nikmahzar, A., Pourshams, A., Sepanlou, S. G., . . . Malekzadeh, R. (2011). The impact of illicit drug use on spontaneous hepatitis C clearance: Experience from a large cohort population study. PLoS ONE, 6(8), e23830. DOI: http://dx.doi.org/10.1371/journal.pone.0023830

  38. Prevots, D.R., Allen, D.M., Lehman, J.S., Green, T.A., Petersen, L.R. & Gwinn, M. (1996). Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988– 1993. American Journal of Epidemiology, 143, 733–742. DOI: https://doi. org/10.1093/oxfordjournals.aje.a008807

  39. Quer, J. y Estaban-Mur, J. I. (2014). Hepatitis C virus: Epidemiology and prevention. in Thomas, H. C., Lok, A. S. F., Locarnini, S. A., & Zuckerman, A. J. (Eds.). Viral Hepatitis (246-265). UK: Wiley Blackwell

  40. Rosenberg, S. D., Goodman, L. a, Osher, F. C., Swartz, M. S., Essock, S. M., Butterfield, M. I., … Salyers, M. P. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91(1), 31-7.

  41. Schackman, B. R., Metsch, L. R., Colfax, G. N., Leff, J. A., Wong, A., Scott, C. A., ... & Walensky, R. P. (2013). The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug and alcohol dependence, 128(1), 90-97. DOI: http://dx.doi.org/10.1016/j.drugalcdep.2012.08.009

  42. Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des Jarlais, D. C., Flom, P. L., & Strauss, S. (2007). Non-injection drug use and hepatitis C virus: a systematic review. Drug and alcohol dependence, 89(1), 1-12. DOI: http:// dx.doi.org/10.1016/j.drugalcdep.2006.11.014

  43. Strathdee, S.A., Philbin, M.M., Semple, S.J., Pu, M., Orozovich, P., Martínez, G.,… Patterson, T.L. (2008). Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug and Alcohol Dependence, 92, 132– 40. DOI: http://dx.doi.org/10.1016/j.drugalcdep.2007.07.001

  44. Swan, D., Long, J., Carr, O., Flanagan, J., Irish, H., Keating, S.,… Cullen, W. (2010). Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS Patient Care and STDS, 24, 753–62. DOI:10.1089/apc.2010.0142.

  45. The PLoS Medicine Editors (2011). Speed and Convenience Aren’t Everything with Diagnostics. PLoS Medicine, 8, e1001113. DOI: http://dx.doi.org/10.1371/journal. pmed.1001113

  46. Treloar, C., Hull, P., Dore, G.J. & Grebely, J. (2012). Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug and Alcohol Review, 31, 918–24. DOI: 10.1111/j.1465- 3362.2012.00468.x

  47. Treloar, C., Newland, J., Rance, J. & Hopwood, M. (2010). Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Journal of Viral Hepatitis, 17, 839–44. DOI: 10.1111/j.1365-2893.2009.01250.x

  48. Viani, R. M., Araneta, M. R. G., Ruiz-Calderon, J., Hubbard, P., Lopez, G., Chacón- Cruz, E., & Spector, S. A. (2006). Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico: seroprevalence and correlates of HIV infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(1), 87-92.

  49. White, E.F., Garfein, R.S., Brouwer, K.C., Lozada, R., Ramos, R., Firestone, M., et al. (2007). Prevalence of hepatitis C virus and HIV among injection drug users in two mexican cities bordering the US. Salud Pública Mexico, 49, 165-172. DOI: http://dx.doi.org/10.1590/S0036-36342007000300001




2020     |     www.medigraphic.com